83
61
Growth Score
-5 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
430120
Drug development of Cannabidiol Acids for unmet medical need and rare diseases
About the Company
epm Therapeutics is a biotechnology company developing novel therapies to address unmet medical needs by researching the safety and efficacy of cannabinoid acid derivatives. These innovations represent novel treatment options for millions of patients worldwide covering a wide range of therapeutic conditions. Our current development focus is our
EPM301 that has Orphan Drug (ODD) and Rare Pediatric Disease (RPD) designation by the USFDA and Orphan Drug in the EU for the treatment of hyperphagia (uncontrolled appetite) in Prader-Willi syndrome patients. For more information and where we are on our development timeline, please visit www.epmtherapeutics.com
